These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27751882)

  • 1. The flavivirus capsid protein: Structure, function and perspectives towards drug design.
    Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC
    Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-guided paradigm shifts in flavivirus assembly and maturation mechanisms.
    Nicholls CMR; Sevvana M; Kuhn RJ
    Adv Virus Res; 2020; 108():33-83. PubMed ID: 33837721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies Towards Protease Inhibitors for Emerging Flaviviruses.
    Nitsche C
    Adv Exp Med Biol; 2018; 1062():175-186. PubMed ID: 29845533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of viral and cellular factors on flavivirus entry.
    Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
    Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in flavivirus antiviral drug discovery and vaccine development.
    Ray D; Shi PY
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of flavivirus capsids enhance the cellular environment for viral replication by activating Akt-signalling pathways.
    Airo AM; Urbanowski MD; Lopez-Orozco J; You JH; Skene-Arnold TD; Holmes C; Yamshchikov V; Malik-Soni N; Frappier L; Hobman TC
    Virology; 2018 Mar; 516():147-157. PubMed ID: 29358114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics.
    Zhang X; Zhang Y; Jia R; Wang M; Yin Z; Cheng A
    Vet Res; 2021 Jun; 52(1):98. PubMed ID: 34193256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
    Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
    ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viperin Targets Flavivirus Virulence by Inducing Assembly of Noninfectious Capsid Particles.
    Vonderstein K; Nilsson E; Hubel P; Nygård Skalman L; Upadhyay A; Pasto J; Pichlmair A; Lundmark R; Överby AK
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Functional Properties of the Capsid Protein of Dengue and Related
    Faustino AF; Martins AS; Karguth N; Artilheiro V; Enguita FJ; Ricardo JC; Santos NC; Martins IC
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Targets for the Treatment of Flavivirus Infections.
    Zakaria MK; Carletti T; Marcello A
    Front Cell Infect Microbiol; 2018; 8():398. PubMed ID: 30483483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and functionality in flavivirus NS-proteins: perspectives for drug design.
    Bollati M; Alvarez K; Assenberg R; Baronti C; Canard B; Cook S; Coutard B; Decroly E; de Lamballerie X; Gould EA; Grard G; Grimes JM; Hilgenfeld R; Jansson AM; Malet H; Mancini EJ; Mastrangelo E; Mattevi A; Milani M; Moureau G; Neyts J; Owens RJ; Ren J; Selisko B; Speroni S; Steuber H; Stuart DI; Unge T; Bolognesi M
    Antiviral Res; 2010 Aug; 87(2):125-48. PubMed ID: 19945487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights into the Flavivirus Replication Complex.
    van den Elsen K; Quek JP; Luo D
    Viruses; 2021 May; 13(6):. PubMed ID: 34064113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for flavivirus drug discovery.
    Sampath A; Padmanabhan R
    Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in flavivirus drug discovery.
    Kok WM
    Expert Opin Drug Discov; 2016; 11(5):433-45. PubMed ID: 26966889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favipiravir inhibits in vitro Usutu virus replication and delays disease progression in an infection model in mice.
    Segura Guerrero NA; Sharma S; Neyts J; Kaptein SJF
    Antiviral Res; 2018 Dec; 160():137-142. PubMed ID: 30385306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers.
    Mandl CW
    Viral Immunol; 2004; 17(4):461-72. PubMed ID: 15671744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural perspective of the flavivirus life cycle.
    Mukhopadhyay S; Kuhn RJ; Rossmann MG
    Nat Rev Microbiol; 2005 Jan; 3(1):13-22. PubMed ID: 15608696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.